News

Investors in these stocks should be very aware that early-stage biotech stocks have huge upside but also bust potential, and to invest within your risk tolerance accordingly. Billy Duberstein and ...
Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the place on Friday. Both U.S.-based Summit Therapeutics (NASDAQ: SMMT ...
My mudroom is a sea of ill-fitting cleats. My second-grader’s room looks like Lego hosted a rave. As for my older son? I can’t close his dresser because his approach to “folding clothes ...
Commenting on the investment, Shruti Srivastava, investment director at Avaana Capital, said, “Their proprietary insect biotechnology and bioprocessing platform enables the production of ...
A “Why I Run” sticker on the back of her shirt says, “For Art,” but she’s not running at this point. She turns on Boylston. The revelers, the finishers, the spouses, the remaining crowds ...
WASHINGTON — Novavax’s closely watched COVID-19 vaccine is on track for full approval after additional discussions with the Food and Drug Administration, the company said Wednesday.
Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...
To help health care providers tell the difference, a team has created a stretchable, rechargeable sticker that can detect real emotions -- by measuring things like skin temperature and heart rate ...
Chocolate lovers are in for a rude awakening this Easter, with their favorite bars, cherished brands, and even the iconic Cadbury Creme Egg are significantly dearer compared to prior years.
Clips posted online also showed fans slapping Lyon FC stickers on lampposts and street signs. Pictures then revealed how a white Bentley Continental, worth around £250k, that had been parked on ...
After San Francisco biotech company Third Harmonic Bio slashed its staff by half in February, it’s now taking a more drastic step. The inflammatory disease research company’s directors have ...